Comparison of dose calculation methods for brachytherapy of intraocular tumors

Medical Physics

Volumn 38, Issue 1, 2011, Pages 306-316

  Rivard, Mark J ^a   Chiu Tsao, Sou Tung ^b   Finger, Paul T ^c   Meigooni, Ali S ^d   Melhus, Christopher S ^a   Mourtada, Firas ^e,f   Napolitano, Mary E ^g   Rogers, D W O ^h   Thomson, Rowan M ^h   Nath, Ravinder ⁱ  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Quality MediPhys LLC   (United States)

^c NEW YORK EYE CANCER CENTER   (United States)

^d Division of Hematology and Medical Oncology   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g Elekta AB   (Sweden)

^h CARLETON UNIVERSITY   (Canada)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brachytherapy; COMS; dosimetry; eye plaque; intraocular tumors; Monte Carlo simulations; TG 43

Indexed keywords

COMPUTER SOFTWARE; DOSIMETRY; MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY; SIMULATORS; TUMORS;

BRACHYTHERAPY; COMS; EYE PLAQUE; INTRAOCULAR TUMORS; TG-43;

CODES (SYMBOLS);

EID: 78650917920     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3523614     Document Type: Article

References (33)

1. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.," Med. Phys. 0094-2405 31, 633-674 (2004). 10.1118/1.1646040 (Pubitemid 38381028)
2. M. J. Rivard, J. L. M. Venselaar, and L. Beaulieu, " The evolution of brachytherapy treatment planning.," Med. Phys. 0094-2405 36, 2136-2153 (2009). 10.1118/1.3125136
3. M. J. Rivard, L. Beaulieu, and F. Mourtada, " Necessary enhancements to commissioning techniques of brachytherapy treatment planning systems that use model-based dose calculation algorithms.," Med. Phys. 0094-2405 37, 2645-2658 (2010). 10.1118/1.3429131
4. P. T. Finger, K. J. Chin, and G. -P. Yu, " Risk factors for radiation maculopathy after plaque radiation for choroidal melanoma.," Am. J. Ophthalmol. 0002-9394 149, 608-615 (2010). 10.1016/j.ajo.2009.11.006
5. P. T. Finger, " Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy.," Br. J. Ophthamol. 0007-1161 84, 1068-1070 (2000). 10.1136/bjo.84.9.1068
6. J. Earle, R. W. Kline, and D. M. Robertson, " Selection of iodine 125 for the Collaborative Ocular Melanoma Study.," Arch. Ophthalmol. (Chicago) 0003-9950 105, 763-764 (1987).
7. Collaborative Ocular Melanoma Study Group, COMS Manual of Procedures, Ch. 12: Radiation therapy, COMS manual of procedures PB95-179693 (National Technical Information Service, Springfield, VA, 1995).
8. B. S. Hawkins, " The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.," Am. J. Ophthalmol. 0002-9394 138, 936-951 (2004). 10.1016/j.ajo.2004.07.006 (Pubitemid 40040008)
9. COMS, " The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.," Arch. Ophthalmol. (Chicago) 0003-9950 124, 1684-1693 (2006). 10.1001/archopht.124.12.1684 (Pubitemid 44913190)
10. R. Kline and J. Earle, " Implications of TG-43 for dose prescription and calculation for I-125 eye plaques.," Med. Phys. 0094-2405 23, 1054 (1996) (abstract). 10.1118/1.597889
11. W. Hanson, " Implementation of the new I-125 standard and TG-43 recommendations in a cooperative clinical trial.," Med. Phys. 23, 1054 (1996) (abstract).
12. S. Nag, J. M. Quivey, J. D. Earle, D. Followill, J. Fontanesi, and P. T. Finger, " The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 56, 544-555 (2003). 10.1016/S0360-3016(03)00006-3 (Pubitemid 36542915)
13. S. -T. Chiu-Tsao, L. L. Anderson, K. O'Brien, L. Stabile, and J. C. Liu, " Dosimetry for I 125 seed (model 6711) in eye plaques.," Med. Phys. 0094-2405 20, 383-389 (1993). 10.1118/1.597164 (Pubitemid 23136207)
14. S-T. Chiu-Tsao, L. L. Boulay, I. H. Kanna, A. de la Zerda, and J. H. Kim, " Dose distribution in the eye for P 103 d COMS eye plaque.," Med. Phys. 0094-2405 22, 923 (1995) (abstract).
15. 125I eye plaque dose distribution including penumbra characteristics.," Med. Phys. 0094-2405 23, 407-418 (1996). 10.1118/1.597803 (Pubitemid 26095697)
16. A. L. Krintz, W. F. Hanson, G. S. Ibbott, and D. S. Followill, " A reanalysis of the Collaborative Ocular Melanoma Study Medium Tumor Trial eye plaque dosimetry.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 56, 889-898 (2003). 10.1016/S0360-3016(03)00211-6 (Pubitemid 36677386)
17. M. A. Astrahan, G. Luxton, G. Jozsef, T. D. Kampp, P. E. Liggett, M. D. Sapozink, and Z. Petrovich, " An interactive treatment planning system for ophthalmic plaque radiotherapy.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 18, 679-687 (1990). 10.1016/0360-3016(90)90077-W
18. M. A. Astrahan, " Improved treatment planning for COMS eye plaques.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 61, 1227-1242 (2005). 10.1016/j.ijrobp.2004.09.062
19. C. S. Melhus and M. J. Rivard, " COMS eye plaque brachytherapy dosimetry simulations for P 103 d, I 125, and C 131 s.," Med. Phys. 0094-2405 35, 3364-3371 (2008). 10.1118/1.2940604 (Pubitemid 351904539)
20. R. M. Thomson, R. E. Taylor, and D. W. O. Rogers, " Monte Carlo dosimetry for I 125 and P 103 d eye plaque brachytherapy.," Med. Phys. 0094-2405 35, 5530-5543 (2008). 10.1118/1.3002412
21. M. J. Rivard, C. S. Melhus, S. Sioshansi, and J. Morr, " The impact of prescription depth, dose rate, plaque size, and source loading on the central-axis using P 103 d, I 125, and C 131 s.," Brachytherapy 1538-4721 7, 327-335 (2008). 10.1016/j.brachy.2008.05.002
22. H. Zhang, D. Martin, S. -T. Chiu-Tsao, A. Meigooni, and B. R. Thomadsen, " A comprehensive dosimetric comparison between C 131 s and I 125 brachytherapy sources for COMS eye plaque implant.," Brachytherapy 9, 362-372 (2010). 10.1016/j.brachy.2009.07.007
23. X-5 Monte Carlo Team, MCNP-A General Monte Carlo N-Particle Transport Code, Version 5 (Los Alamos National Laboratory, Los Alamos, NM, 2003).
24. G. Yegin, R. E. P. Taylor, and D. W. O. Rogers, " BrachyDose: A new fast Monte Carlo code for brachytherapy calculations.," Med. Phys. 0094-2405 33, 2075 (2006) (abstract). 10.1118/1.2241038
25. I. Kawrakow and D. W. O. Rogers, " The EGSnrc code system: Monte Carlo simulation of electro and photon transport.," NRC Report No. PIRS-701, Ottawa K1A 0R6, 2007, http://www.irs.inms.nrc.ca/inms/irs/EGSnrc/ EGSnrc.html last accessed 5 December 2010.
26. J. Dolan, Z. Li, and J. F. Williamson, " Monte Carlo and experimental dosimetry of an I 125 brachytherapy seed.," Med. Phys. 0094-2405 33, 4675-4684 (2006). 10.1118/1.2388158 (Pubitemid 44868105)
27. J. I. Monroe and J. F. Williamson, " Monte Carlo-aided dosimetry of the Theragenics TheraSeed model 200 P 103 d interstitial brachytherapy seed.," Med. Phys. 0094-2405 29, 609-621 (2002). 10.1118/1.1460876 (Pubitemid 34408775)
28. R. E. P. Taylor, G. Yegin, and D. W. O. Rogers, " Benchmarking BrachyDose: Voxel based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters.," Med. Phys. 0094-2405 34, 445-457 (2007). 10.1118/1.2400843 (Pubitemid 46185122)
29. R. E. P. Taylor and D. W. O. Rogers, " An EGSnrc Monte Carlo-calculated database of TG-43 parameters.," Med. Phys. 0094-2405 35, 4228-4241 (2008). 10.1118/1.2965360
30. R. M. Thomson and D. W. O. Rogers, " Monte Carlo dosimetry for I 125 and P 103 d eye plaque brachytherapy with various seed models.," Med. Phys. 0094-2405 37, 368-376 (2010). 10.1118/1.3271104
31. S. -T. Chiu-Tsao, in Brachytherapy Physics, edited by, B. R. Thomadsen, M. J. Rivard, and, W. M. Butler, (Medical Physics, Madison, Wisconsin, 2005), pp. 673-705.
32. P. T. Finger, K. J. Chin, G. -P. Yu, and N. S. Patel, " Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 (in press).
33. R. M. Thomson, K. M. Furutani, J. S. Pulido, S. L. Stafford, and D. W. O. Rogers, " Modified COMS plaques for I 125 and P 103 d iris melanoma brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 78, 1261-1269 (2010). 10.1016/j.ijrobp.2009.12.002